MeSH Review:
Oncogenes
- Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification. Caron, H., van Sluis, P., van Hoeve, M., de Kraker, J., Bras, J., Slater, R., Mannens, M., Voûte, P.A., Westerveld, A., Versteeg, R. Nat. Genet. (1993)
- Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer. Anand, N., Murthy, S., Amann, G., Wernick, M., Porter, L.A., Cukier, I.H., Collins, C., Gray, J.W., Diebold, J., Demetrick, D.J., Lee, J.M. Nat. Genet. (2002)
- Phosphorylation of tyrosine-416 is not required for the transforming properties and kinase activity of pp60v-src. Snyder, M.A., Bishop, J.M., Colby, W.W., Levinson, A.D. Cell (1983)
- An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Wang, D., Liebowitz, D., Kieff, E. Cell (1985)
- Expression of the PDGF-related transforming protein of simian sarcoma virus in E. coli. Devare, S.G., Shatzman, A., Robbins, K.C., Rosenberg, M., Aaronson, S.A. Cell (1984)
- The ras and myc oncogenes cooperate in tumor induction in many tissues when introduced into midgestation mouse embryos by retroviral vectors. Compere, S.J., Baldacci, P., Sharpe, A.H., Thompson, T., Land, H., Jaenisch, R. Proc. Natl. Acad. Sci. U.S.A. (1989)
- Role for PP2A in ARF signaling to p53. Moule, M.G., Collins, C.H., McCormick, F., Fried, M. Proc. Natl. Acad. Sci. U.S.A. (2004)
- Onc genes and other new targets for cancer chemotherapy. Busch, H. J. Cancer Res. Clin. Oncol. (1984)
- Increased c-myc oncogene expression in Ewing's sarcoma: correlation with Ki67 proliferation index. Sollazzo, M.R., Benassi, M.S., Magagnoli, G., Gamberi, G., Molendini, L., Ragazzini, P., Merli, M., Ferrari, C., Balladelli, A., Picci, P. Tumori. (1999)
- Connexins, connexons, and intercellular communication. Goodenough, D.A., Goliger, J.A., Paul, D.L. Annu. Rev. Biochem. (1996)
- The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome. Li, X., Lonard, D.M., Jung, S.Y., Malovannaya, A., Feng, Q., Qin, J., Tsai, S.Y., Tsai, M.J., O'Malley, B.W. Cell (2006)
- A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Voorhoeve, P.M., le Sage, C., Schrier, M., Gillis, A.J., Stoop, H., Nagel, R., Liu, Y.P., van Duijse, J., Drost, J., Griekspoor, A., Zlotorynski, E., Yabuta, N., De Vita, G., Nojima, H., Looijenga, L.H., Agami, R. Cell (2006)
- The evi5 oncogene regulates cyclin accumulation by stabilizing the anaphase-promoting complex inhibitor emi1. Eldridge, A.G., Loktev, A.V., Hansen, D.V., Verschuren, E.W., Reimann, J.D., Jackson, P.K. Cell (2006)
- The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Huang, J., Wu, S., Barrera, J., Matthews, K., Pan, D. Cell (2005)
- Mechanism of met oncogene activation. Park, M., Dean, M., Cooper, C.S., Schmidt, M., O'Brien, S.J., Blair, D.G., Vande Woude, G.F. Cell (1986)
- Modulation of GABAA receptors by tyrosine phosphorylation. Moss, S.J., Gorrie, G.H., Amato, A., Smart, T.G. Nature (1995)
- Effect of cyclophosphamide therapy on oncogene expression in angioimmunoblastic lymphadenopathy. Klinman, D.M., Steinberg, A.D., Mushinski, J.F. Lancet (1986)
- Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase. Salmeron, A., Ahmad, T.B., Carlile, G.W., Pappin, D., Narsimhan, R.P., Ley, S.C. EMBO J. (1996)
- AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. Cheng, J.Q., Godwin, A.K., Bellacosa, A., Taguchi, T., Franke, T.F., Hamilton, T.C., Tsichlis, P.N., Testa, J.R. Proc. Natl. Acad. Sci. U.S.A. (1992)
- Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Tanaka, N., Ishihara, M., Kitagawa, M., Harada, H., Kimura, T., Matsuyama, T., Lamphier, M.S., Aizawa, S., Mak, T.W., Taniguchi, T. Cell (1994)
- Ectopic expression of MITF, a gene for Waardenburg syndrome type 2, converts fibroblasts to cells with melanocyte characteristics. Tachibana, M., Takeda, K., Nobukuni, Y., Urabe, K., Long, J.E., Meyers, K.A., Aaronson, S.A., Miki, T. Nat. Genet. (1996)
- Nucleotide sequences of feline retroviral oncogenes (v-fes) provide evidence for a family of tyrosine-specific protein kinase genes. Hampe, A., Laprevotte, I., Galibert, F., Fedele, L.A., Sherr, C.J. Cell (1982)
- The c-Ha-ras oncogene and a tumor promoter activate the polyoma virus enhancer. Wasylyk, C., Imler, J.L., Perez-Mutul, J., Wasylyk, B. Cell (1987)
- A transactivation-deficient mouse model provides insights into Trp53 regulation and function. Jimenez, G.S., Nister, M., Stommel, J.M., Beeche, M., Barcarse, E.A., Zhang, X.Q., O'Gorman, S., Wahl, G.M. Nat. Genet. (2000)
- PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Grieco, M., Santoro, M., Berlingieri, M.T., Melillo, R.M., Donghi, R., Bongarzone, I., Pierotti, M.A., Della Porta, G., Fusco, A., Vecchio, G. Cell (1990)
- Trypanosome invasion of mammalian cells requires activation of the TGF beta signaling pathway. Ming, M., Ewen, M.E., Pereira, M.E. Cell (1995)
- Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice. Matsui, Y., Halter, S.A., Holt, J.T., Hogan, B.L., Coffey, R.J. Cell (1990)
- Transmembrane orientation of glycoproteins encoded by the v-fms oncogene. Rettenmier, C.W., Roussel, M.F., Quinn, C.O., Kitchingman, G.R., Look, A.T., Sherr, C.J. Cell (1985)
- Dominant negative MYC blocks transformation by ABL oncogenes. Sawyers, C.L., Callahan, W., Witte, O.N. Cell (1992)
- Modular structure of a chicken lysozyme silencer: involvement of an unusual thyroid hormone receptor binding site. Baniahmad, A., Steiner, C., Köhne, A.C., Renkawitz, R. Cell (1990)
- A novel mechanism of action for v-ErbA: abrogation of the inactivation of transcription factor AP-1 by retinoic acid and thyroid hormone receptors. Desbois, C., Aubert, D., Legrand, C., Pain, B., Samarut, J. Cell (1991)
- Identification of functional regions in the transforming protein of Fujinami sarcoma virus by in-phase insertion mutagenesis. Stone, J.C., Atkinson, T., Smith, M., Pawson, T. Cell (1984)
- Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Dickins, R.A., Hemann, M.T., Zilfou, J.T., Simpson, D.R., Ibarra, I., Hannon, G.J., Lowe, S.W. Nat. Genet. (2005)
- Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Serrano, M., Lin, A.W., McCurrach, M.E., Beach, D., Lowe, S.W. Cell (1997)
- Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Graux, C., Cools, J., Melotte, C., Quentmeier, H., Ferrando, A., Levine, R., Vermeesch, J.R., Stul, M., Dutta, B., Boeckx, N., Bosly, A., Heimann, P., Uyttebroeck, A., Mentens, N., Somers, R., MacLeod, R.A., Drexler, H.G., Look, A.T., Gilliland, D.G., Michaux, L., Vandenberghe, P., Wlodarska, I., Marynen, P., Hagemeijer, A. Nat. Genet. (2004)
- Multiple tumor suppressor pathways negatively regulate telomerase. Lin, S.Y., Elledge, S.J. Cell (2003)
- Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Kakizuka, A., Miller, W.H., Umesono, K., Warrell, R.P., Frankel, S.R., Murty, V.V., Dmitrovsky, E., Evans, R.M. Cell (1991)
- Stat3 as an oncogene. Bromberg, J.F., Wrzeszczynska, M.H., Devgan, G., Zhao, Y., Pestell, R.G., Albanese, C., Darnell, J.E. Cell (1999)
- Molecular cloning and characterization of PEA3, a new member of the Ets oncogene family that is differentially expressed in mouse embryonic cells. Xin, J.H., Cowie, A., Lachance, P., Hassell, J.A. Genes Dev. (1992)
- Raf-1 antagonizes erythroid differentiation by restraining caspase activation. Kolbus, A., Pilat, S., Husak, Z., Deiner, E.M., Stengl, G., Beug, H., Baccarini, M. J. Exp. Med. (2002)
- Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. Warrell, R.P., He, L.Z., Richon, V., Calleja, E., Pandolfi, P.P. J. Natl. Cancer Inst. (1998)
- Replacement of lys 622 in the ATP binding domain of P100gag-mil abolishes the in vitro autophosphorylation of the protein and the biological properties of the v-mil oncogene of MH2 virus. Denhez, F., Heimann, B., d'Auriol, L., Graf, T., Coquillaud, M., Coll, J., Galibert, F., Moelling, K., Stehelin, D., Ghysdael, J. EMBO J. (1988)
- Human c-fos oncogene mapped within chromosomal region 14q21----q31. Barker, P.E., Rabin, M., Watson, M., Breg, W.R., Ruddle, F.H., Verma, I.M. Proc. Natl. Acad. Sci. U.S.A. (1984)